申请人:Yeda Research and Development Co. Ltd.
公开号:US20210292338A1
公开(公告)日:2021-09-23
Described herein are compounds having Formula I or Formula II:
wherein each dashed line independently represents a saturated or unsaturated bond; R
1
and R′
1
are aryl or heteroaryl as defined herein; and R
2
and R′
2
are as defined herein. Further described is a method of inhibiting nuclear translocation of ERK1/2 in a cell, by contacting the cell with a compound having Formula I or Formula II. The compounds may also be for use in treating a disease or disorder associated with nuclear translocation of ERK1/2.